CD
ELV icon

Christopher Davis’s Elevance Health ELV Stock Holding History

Christopher Davis’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-39,238
Closed -$6.06M – 191
2015
Q1 		$6.06M Sell
39,238
-14,320
-27% -$2.04M 0.02% 152
2014
Q4 		$6.73M Sell
53,558
-163
-0.3% -$20.1K 0.02% 145
2014
Q3 		$6.43M Sell
53,721
-3,377
-6% -$387K 0.02% 149
2014
Q2 		$6.14M Sell
57,098
-29,949
-34% -$3.09M 0.02% 153
2014
Q1 		$8.67M Sell
87,047
-13,294
-13% -$1.2M 0.02% 129
2013
Q4 		$9.27M Buy
100,341
+92,461
+1,173% +$8.22M 0.02% 129
2013
Q3 		$659K Hold
7,880
– – ﹤0.01% 175
2013
Q2 		$645K Buy
+7,880
New +$590K ﹤0.01% 190

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Christopher Davis's ELV Position: Q2 2015 in Review

Christopher Davis sold out of Elevance Health (ELV) in Q2 2015, closing a stake of 39,238 shares — an estimated $6.06M sold.

Christopher Davis first reported a position in ELV in Q2 2013 and held it in 8 quarters. The position peaked at $9.27M in Q4 2013. 781 funds tracked by Wall St. Rank hold ELV as of Q2 2015.

  • Christopher Davis reported no remaining Elevance Health position as of Q2 2015 after selling out during the quarter.
  • Christopher Davis sold 39,238 Elevance Health shares in Q2 2015, an estimated $6.06M.
  • Christopher Davis first reported a position in Elevance Health in Q2 2013 and held it in 8 quarters.
  • Christopher Davis's Elevance Health position peaked at $9.27M in Q4 2013.
  • 781 funds tracked by Wall St. Rank held Elevance Health as of Q2 2015.

Based on Davis Selected Advisers's 13F filing for Q2 2015, filed 13 Aug 2015.